Insilico Medicine Aw
Insilico Medicine Awarded Over $700,000 to Design New Contraceptive Options with AI
November 23, 2022 09:00 ET | InSilico Medicine
New York, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, is designing new non-hormonal contraceptive...
Advancing AI Drug Discovery
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
November 08, 2022 09:00 ET | InSilico Medicine
Abu Dhabi, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...
Advancing AI Drug Discovery
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
November 08, 2022 09:00 ET | InSilico Medicine
New York, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...
Petrina Kamya, PhD, Head of AI Platforms at Insilico Medicine
Deepfake Technology in Drug Design
October 20, 2022 12:00 ET | InSilico Medicine
New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage artificial intelligence (AI)-driven drug discovery company, is utilizing the same deepfake technology used to create...
Insilico Medicine signs MoU with Saudi Ministry of Investment
Saudi Ministry of Investment and Insilico Medicine sign agreement to expand region’s biotechnology capabilities
September 14, 2022 09:32 ET | InSilico Medicine
New York, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Saudi Arabia’s Ministry of Investment (MISA) and clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine have signed...
Insilico Medicine An
Insilico Medicine Announces New Investment Led by Aramco-backed Prosperity7 Ventures, bringing total Series D Financing to $95 Million
August 10, 2022 08:50 ET | InSilico Medicine
New York, Aug. 10, 2022 (GLOBE NEWSWIRE) -- HIGHLIGHTS: ●      Insilico Medicine announces a closing of its Series D2 round, bringing the total Series D financing to $95 million, despite an...
Sujata Rao, MD
Insilico Medicine Appoints Sujata Rao, M.D., as Senior Vice President to Oversee Clinical Development
July 19, 2022 10:00 ET | InSilico Medicine
New York, July 19, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI) driven drug discovery company, has appointed Dr. Sujata Rao as Senior Vice...
英矽智能利用其人工智能驱动的靶点识别引擎
英矽智能利用其人工智能驱动的靶点识别引擎,发现了多个肌萎缩侧索硬化症(ALS)的潜力靶点
July 07, 2022 13:22 ET | Insilico Medicine
英矽智能及其合作伙伴通过其自主研发的人工智能靶点识别引擎PandaOmics™,搜索了大量的数据集并找到了与ALS相关的基因。研究团队从中枢神经系统样本库和由干细胞诱导分化成的运动神经元样本库中发现了28个靶点,其中64%即18个靶点被证明,其抑制对神经退行性变具有适度或强烈减缓作用。这项合作研究由英矽智能主导,得到了Answer...
Discovering New Therapeutic Targets for ALS Using AI
Insilico Medicine identified multiple new targets for amyotrophic lateral sclerosis (ALS) using its AI-driven target discovery engine
July 07, 2022 09:00 ET | InSilico Medicine
New York, July 07, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the company has identified...
Insilico Medicine Launches Aging.AI - Deep-Learned Predictor of Age Trained on Millions of Blood Tests
February 22, 2016 10:08 ET | InSilico Medicine
BALTIMORE, Md., Feb. 22, 2016 (GLOBE NEWSWIRE) -- via PRWEB - Insilico Medicine launched aging.AI, a system allowing users to guess their age and gender by entering the results of their blood test....